Transplantation Immunology
ORGAN transplantation is one of the most exciting and rapidly advancing branches of medical science. It is also one of the most challenging, for although the highly sophisticated surgical techniques which are involved are now available, the immunological barrier is still regarded as an important impediment to successful organ transplantation. In recent years suppression of the immune response and prolongation of the life of homografts have been achieved by the use of several immunosuppressive agents, including the most recent, antilymphocytic serum. Furthermore, great advances in the recognition of tissue antigens have enabled the compatibility of donor and recipient to be established before surgical transplantation is attempted.
The Immune Response
The basic principles of homograft rejection have been known for well over a decade, but only recently has a detailed picture been constructed. Recognition of the presence of foreign antigenic material in the recipient triggers off the sequence of events that results in the destruction of the graft. There are two possible ways-which are not mutually exclusive-by which the presence of a graft is signalled to the host's regional lymph nodes 1 . Antigenic material may pass from the graft into the recipient's afferent lymphatics and be carried to the lymphoid organs; alternatively, lymphocytes may be carried to the graft by the vascular system, be sensitized, and then return to the recipient's lymphoid organs. According to Gowans and his colleagues, it is the small lymphocytes that are the key participants in the recognition of transplantation antigens. These small lymphocytes, which are less than 8µ in diameter, form the bulk of lymphocytes in lymphoid tissue, blood and lymph and are characterized by their polarized mobility and long life span 2 • Whatever the method of sensitization, large numbers of small lymphocytes within the lymph nodes are stimulated to undergo transformation and to divide repeatedly, forming "immunologically committed" or effector cells. Informational molecules of RNA may be passed directly from one lymphocyte to another, or they may be passed through the mediation of phagocytes. Activated lymphocytes are then released into the blood stream through the efferent lymphatics and are carried to the site of the graft. Although it is these small lymphocytes that seem to cause most of the damage to grafts, humoral (soluble) antibody may be involved in some cases. Another possibility is that graft destruction is brought about by macro-phages3.
Several suggestions have been made about how lymphocytes fulfil their cytopathogenic role in graft destruction 4 • One is that they synthesize an antibody that is normally released only when the lymphocytes are in intimate contact with homologous target cells or antigenic material in the graft.
Alternatively, lymphocytes may not synthesize antibody, but carry on their surfaces an effective cell-bound antibody, with a special affinity for graft cells, which is synthesized elsewhere in the body. A third possibility is that lymphocytes synthesize a special kind of antibody which is permanently incorporated on their surface and which is only effective when intimate contact with a target cell has been established. A fourth suggestion is that lymphocytes do not themselves mediate graft rejection , but release or secrete, and/or possibly cause other host cells to release, some non-specific pharmacologically active agent analogous to histamine. Contact between incompatible surfaces has also been invoked to explain the damage to grafts. It seems that the way in which a graft is damaged varies according to the organ, but one common effect is the obstruction of the flow of blood through the vessels in the graft. This is obviously an important topic for research, because a complete knowledge of the mechanisms underlying graft rejection is essential to an understanding of the way in which immunosuppressive agents exert their effect.
lmmunosuppressive Agents
Direct irradiation (usually deep X-rays) is seldom used now for suppressing the immune response. During the past six years it has largely been replaced by the cytotoxic drugs-particularly azathioprine. Azathioprine (Imuran), like 6-mercaptopurine, is a purine analogue; it interferes with the stimulation of small lymphocytes and also kills some of the cells that divide after stimulation. Its chief disadvantage is its lack of specificity and its toxic effects on the liver and bone marrow. Another drug, Prednisone, a synthetic adrenal cortical hormone, is especially valuable during rejection episodes when the response to a graft is maximal, but, like azathioprine, it is non-specific; nevertheless the combined use of these two drugs has led to the survival for years of some hundreds of patients with transplanted kidneys.
The value of antilymphocytic serum (ALS)-w·hich has been described by Medawar 5 as "the only true immunosuppressant agent"-in prolonging the life of homografts was first definitely shown by Woodruff and Anderson in 1963 (ref. 6) . By injecting lymphocytes from rats into rabbits, collecting the rabbit serum and injecting this into rats, they were able to prolong the life of skin grafts from another breed of rats for up to 46 days. Since then the beneficial effect of ALS after whole organ transplantation in outbrcd animals has been demonstrated; the chances of inducing acute symptoms have been reduced by the use of antilymphocytic immune globulin (IgG) instead of the whole serum, for it is in this fraction that the immunosuppressive activity resides.
Even though antilymphocytic IgG is relatively non-toxic, two undesirable effects are the pain experienced by patients at the site of injection, and the fact that they often become feverish.
Antilymphocytic globulin has been used in conjunction with azathioprine and prednisoue in more than fifty kidney allotransplant recipients by Starzl et al. (Woodruff, personal communication) . Of 20 recipients who received kidneys from related donors 7 , nineteen were alive and showed good graft function ten to sixteen months later; the expected death rate in the light of previous experiments without antilym-phocytic IgG would have been about 30 per cent. Woodruff and his colleagues have also administered antilymphocytic IgG to six kidney transplant recipients, but in this case the results are less easy to evaluate (personal communication). Starzl and his colleagues have also obtained good results in liver transplant recipients given antilymphocytic IgG in conjunction with azathioprine.
So far there is no general agreement about the reason why ALS has this remarkable ability to prolong the life of homografts. lt is, however, well established that ALS is highly but not completely specific in that it suppresses the cellular immune response to grafts but causes much less marked suppression of antibody synthesis. The earlier view that ALS causes general lymphoid depletion is no longer considered to be adequate for explaining how ALS functions. Similarly, the suggestion that ALS in some way "coats" lymphocytes, making them immunologically ineffective, has been strongly criticized. Anderson, James and ,voodruff 8 have recently shown that the properties of ALS are not dependent on antigenic competition. (ALS acts as an antigen as well as being an antibody or complex of antibodies.) A likely suggestion that has been put forward by Taub (Woodruff, personal communication) is that ALS brings about selective depletion of the pool of longlived small lymphocytes. This would seem to be borne out by recent experiments of Denman et al. 9 , who found that the blood and lymphoid tissue of mice which had received a course of rabbit antilymphocytic IgG were depleted of long-lived small lymphocytes. This deficiency was made good by an immigrant population of short-lived small lymphocytes, evidently produced by actively proliferating precursor cells in the lymphoid tissue. Primary immune responsiveness, however, was not, restored in the absence of longer living lymphocytes.
A particularly interesting aspect of ALS is that its effect outlives its own metabolic lifetime 10 • In other words, homografts which have been caused to survive by the administration of ALS continue to survive long after ALS has been reduced by metabolic processes to a concentration at which it would be quite ineffective if newly administered as an immunosuppressive agent. Levey and Medawar have observed that skin homografts in mice sometimes live for at least 100 days u.ftcr receiving as little as one millilitre of ALS. This leads quite naturally to the concept of tolerance.
Tolerance
Tolerance has been defined as a central failure of responsiveness brought about by exposure to antigens, in which immunologically competent cells become unable to initiate the synthesis of a restricted range of antibodies 11 • These competent cells are now known to be the small lymphocytes. There is much interest in this subject because of its possible future applications in transplantation surgery. In animals, the barrier that the homograft response imposes has frequently been overcome by treating the recipient with donor antigens, thereby inducing a state of tolerance or paralysis. If human recipients could be made to tolerate a graft, the clinical dependence on immunosuppressive drugs would be greatly reduced.
The way in which antigens paralyse lymphocytes is still a mystery, although it seems that direct interaction NATURE. VOL. 219. AUGUST 24. 1968 of antigens with lymphocytes is involved. This suggests that lymphocytes carry special receptors that "recognize" antigen. The outcome of the interaction is that lymphocytes are either killed or irreversibly inactivated so that they can no longer respond to antigenic stimuli 11 . Lance and Medawar 12 have recently described an experiment in which the administration of ALS abetted the induction of immunological tolerance of hetcrografts-a particularly difficult enterprise. In essence they significantly prolonged the life of skin heterografts from August strain rats on adult mice of the strain CBA by reinforcing the antigenic dose with intravenous injections of August rat thymocytes five to seven days after the end of treatment with ALS. Although the longest survival time was only forty days after the last injection of ALS, their work paves the way to the induction of a true specific tolerance of a more lasting nature. The same series of experiments provided evidEnce that, in some experimental systems at least, the factors inhibiting transplantation of heterografts are immunological.
At present Caine et al. 13 are carrying out grafts between pigs and baboons and the long term aim of this work is to devise methods for transplanting animal organs into humans as an answer to the shortage of human organs.
Tissue Typing
Antigens distinct from those carried by red blood cells have been recognized and identified in the tissue of many species including man. As a result, by the application of immunological methods it is now possible J<'ig. 1 . The Nuflield Transplantation Surgery Unit in Edinburgh was officially opened on Jan nary 31 by Sir l'eter Medawar. The unit, which cost more than .C200,000 has accommodation for six patients and will cater for three principal categories: organ transplant recipients; cancer patients receiving treatment that renders them susceptible to infection; and J)at.ients with certain types of im1nune disease. Designed by Mr Peter Womersley, the unit has an aseptic core with corridors encompassing three sides, leaving tho fourth available for expansion. The tower houses the main stairs, filter cha.mber and water storage. , VOL. 219, AUGUST 24, 1968 to select, for organ exchange, pairs of donors and recipients with a minimum of antigenic differences. Results which have been obtained so far indicate that this procedure leads to a reduced immune response and to prolonged survival of grafts in some systems. A precise determination of the value of tissue matching will, however, depend on statistical analysis of data obtained by following the progress of graft recipients over a suitable period of time.
NATURE
Histocompatibility antigens are distributed in varying quantities in different tissues. Some cells, for example striated muscle cells, probably have negligible amounts of these antigens, whereas other cells, particularly lymphoid cells, bear relatively large quantities.
The two most commonly used techniques for matching the tissues of a donor and recipient are the agglutination test and the cytotoxicity test. Although the agglutination test is slightly the more rapid of the two, it is less widely used because of technical difficulties. It consists essentially of taking blood from the prospective donor and recipient, separating the white cells and mixing these separately with a range of blood sera. Each antiserum contains an antibody against one or other of the known transplantation antigens. If the white cells agglutinate, that is if they clump together, they obviously have the antigen which reacts with the particular antibody. In this way, information can be obtained about all the antigens that are present in the white blood cells of donor and recipient. This test takes about one and a half hours.
In the cytotoxicity test, extracted lymphocytes are again mixed with various antisera, and in this case a complex of substances called complement is added~ If lymphocytes carry the antigen against which a particular antiserum is directed, antigen and antibody combine and in the presence of complement they destroy the cells. This test usually takes three hours to perform.
Lymphocytes
Another technique is based on the fact that iflymphocytes from antigenically different individuals are cultured together, the cells begin to divide; this is thought to represent the beginning of the immune response. Division is detected either by counting the number of large cells or by following the uptake of radioactive substances such as tritiated thymidine.
The immunogenetic basis for histocompatibility was first worked out in mice by Gorer. In this species, fifteen independent genetic loci which affect graft survival have been identified and more are known to exist. Of the many loci which are now known for the mouse, one of them-the H-2 locus-seems to determine "strong" antigens which cause rapid rejection of grafts. It is not really known why certain antigenic differences are more important than others as far as graft rejection is concerned. One possibility is that the strength of a transplantation antigen depends on the amount of antigen present on a tissue cell. Another possibility is that it depends on a qualitative feature of the antigen macromolecule. Yet another possibility is that it may be the position of the antigens on the surface of the cell which determines whether or not they induce rapid rejection.
It has now been established beyond doubt that a complex antigenic system closely resembling the H-2 system in the mouse, and analogous to the rhesus 835 system, exists in man. Although different names have been given to it by various workers, it is now generally known as the HL-A system.
Extending earlier work by Van Rood and others, Batchelor and Chapman 14 have investigated the lymphocyte antigens of eighteen families. This work confirmed previous results that most of the antigens that have been recognized in human white blood cells belong to the same genetic system and are inherited en bloc. Batchelor and Chapman have identified twenty-six antigens within the HL-A system whereas Van Rood identified only ten, and Dausset and coworkers identified fourteen 15 . These differences between results from different laboratories have come about partly because different criteria have been adopted for the definition of antigens.
Evidence for the effect of tissue matching on the survival of grafts is rather complicated. In mice, convincing evidence that matching of H-2 ·antigens is important has come from experiments with congenic lines of mice-that is, mice which are genetically identical except for a small difference at a single chromosomal site. Snell has raised a number of strains of these mice differing at different H loci. It is known that when mice are identically matched except for H-2 system antigens, skin grafts are rejected within two weeks. If, however, the congenic mice differ at a non-H-2 locus, skin grafts survive for at least three weeks and longer depending on the precise genetic difference between them.
Although evidence for humans is fragmentary, results are in keeping with experience in lower animals (Batchelor, personal communication) . It has been much easier to prove the value of matching in situations when donors are related to the recipients, and much less easy when donor and recipient are unrelated. For example, skin graft data show that survival times of grafts in serologically matched and unmatched pairs from a random population differ only slightly. But in related pairs, matching of the HL-lt,system antigens leads to a dramatically prolonged survival of grafts. Van Rood and his colleagues have shown that antigen matching is also important in prolonging the life . of kidney grafts from related donors 16 . 
